Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice

The modulation of the gut microbiome has been widely suggested as a promising therapeutic strategy for inflammatory bowel disease (IBD). Here, we established a novel probiotic cocktail to investigate its therapeutic role in acute colitis mice. During dextran sulfate sodium (DSS)-induced colitis, the...

Full description

Bibliographic Details
Main Authors: Yefei Zhu, Yu Xu, Xinyue Wang, Leiping Rao, Xuebing Yan, Renyuan Gao, Tongyi Shen, Yuan Zhou, Cheng Kong, Longxiang Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.886061/full
_version_ 1811337261890928640
author Yefei Zhu
Yefei Zhu
Yefei Zhu
Yu Xu
Yu Xu
Xinyue Wang
Leiping Rao
Xuebing Yan
Renyuan Gao
Tongyi Shen
Yuan Zhou
Cheng Kong
Longxiang Zhou
author_facet Yefei Zhu
Yefei Zhu
Yefei Zhu
Yu Xu
Yu Xu
Xinyue Wang
Leiping Rao
Xuebing Yan
Renyuan Gao
Tongyi Shen
Yuan Zhou
Cheng Kong
Longxiang Zhou
author_sort Yefei Zhu
collection DOAJ
description The modulation of the gut microbiome has been widely suggested as a promising therapeutic strategy for inflammatory bowel disease (IBD). Here, we established a novel probiotic cocktail to investigate its therapeutic role in acute colitis mice. During dextran sulfate sodium (DSS)-induced colitis, the mice were treated with the probiotic cocktail, fecal microbiota transplantation (FMT) from a healthy mice donor, or 5-aminosalicylic acid (5-ASA), respectively. The inflammatory responses were assessed by symptoms, serum inflammatory factors, and histological scoring. The intestinal barrier function was assessed by detecting tight junction proteins. Gut microbiota and its metabolites were further identified using 16S rDNA sequencing and a liquid chromatograph mass spectrometer (LC-MS/MS). Compared with FMT and 5-ASA treatment, the probiotic cocktail performed better in alleviating symptoms of colitis and decreasing disease activity score and mucosal inflammation. The probiotic cocktail also significantly decreased serum IL-17 level and increased JAM-1 expression in colon. The gut microbiota analysis confirmed that the beneficial effects of the probiotic cocktail were attributed to increasing anti-inflammatory bacteria Akkermansia, Bifidobacterium, and Blautia, while decreasing pro-inflammatory bacteria Parasutterella. The targeted metabolome analysis further indicated a rise in the production of Bifidobacterium-related short-chain fatty acids (SCFAs) such as propanoic acid and isobutyric acid after probiotics treatment. Taken together, the probiotic cocktail effectively alleviated intestinal inflammation through improving gut microbiota and metabolites in colitis mice, suggesting its great potential to be a novel therapeutic approach for IBD patients.
first_indexed 2024-04-13T17:52:14Z
format Article
id doaj.art-2e7903f7ef584f1b920978cb43a5668a
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-13T17:52:14Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-2e7903f7ef584f1b920978cb43a5668a2022-12-22T02:36:39ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-06-011210.3389/fcimb.2022.886061886061Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis MiceYefei Zhu0Yefei Zhu1Yefei Zhu2Yu Xu3Yu Xu4Xinyue Wang5Leiping Rao6Xuebing Yan7Renyuan Gao8Tongyi Shen9Yuan Zhou10Cheng Kong11Longxiang Zhou12Research Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaDepartment of General Surgery, Jinshan Branch of Shanghai Sixth People’s Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaSchool of Medicine, Nantong University, Nantong, ChinaResearch Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaSchool of Medicine, Nantong University, Nantong, ChinaResearch Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaDepartment of General Surgery, Jinshan Branch of Shanghai Sixth People’s Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaDepartment of Oncology, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, ChinaResearch Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaResearch Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaSchool of Biological Engineering, Hefei Technology College, Hefei, ChinaResearch Institute of Intestinal Diseases, Tongji University, School of Medicine, Shanghai, ChinaDepartment of General Surgery, Jinshan Branch of Shanghai Sixth People’s Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaThe modulation of the gut microbiome has been widely suggested as a promising therapeutic strategy for inflammatory bowel disease (IBD). Here, we established a novel probiotic cocktail to investigate its therapeutic role in acute colitis mice. During dextran sulfate sodium (DSS)-induced colitis, the mice were treated with the probiotic cocktail, fecal microbiota transplantation (FMT) from a healthy mice donor, or 5-aminosalicylic acid (5-ASA), respectively. The inflammatory responses were assessed by symptoms, serum inflammatory factors, and histological scoring. The intestinal barrier function was assessed by detecting tight junction proteins. Gut microbiota and its metabolites were further identified using 16S rDNA sequencing and a liquid chromatograph mass spectrometer (LC-MS/MS). Compared with FMT and 5-ASA treatment, the probiotic cocktail performed better in alleviating symptoms of colitis and decreasing disease activity score and mucosal inflammation. The probiotic cocktail also significantly decreased serum IL-17 level and increased JAM-1 expression in colon. The gut microbiota analysis confirmed that the beneficial effects of the probiotic cocktail were attributed to increasing anti-inflammatory bacteria Akkermansia, Bifidobacterium, and Blautia, while decreasing pro-inflammatory bacteria Parasutterella. The targeted metabolome analysis further indicated a rise in the production of Bifidobacterium-related short-chain fatty acids (SCFAs) such as propanoic acid and isobutyric acid after probiotics treatment. Taken together, the probiotic cocktail effectively alleviated intestinal inflammation through improving gut microbiota and metabolites in colitis mice, suggesting its great potential to be a novel therapeutic approach for IBD patients.https://www.frontiersin.org/articles/10.3389/fcimb.2022.886061/fullgut microbiomegut barriershort-chain fatty acids (SCFAs)liquid chromatograph mass spectrometer (LC-MS/MS)inflammatory bowel disease (IBD)fecal microbiota transplantation (FMT)
spellingShingle Yefei Zhu
Yefei Zhu
Yefei Zhu
Yu Xu
Yu Xu
Xinyue Wang
Leiping Rao
Xuebing Yan
Renyuan Gao
Tongyi Shen
Yuan Zhou
Cheng Kong
Longxiang Zhou
Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
Frontiers in Cellular and Infection Microbiology
gut microbiome
gut barrier
short-chain fatty acids (SCFAs)
liquid chromatograph mass spectrometer (LC-MS/MS)
inflammatory bowel disease (IBD)
fecal microbiota transplantation (FMT)
title Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
title_full Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
title_fullStr Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
title_full_unstemmed Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
title_short Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
title_sort probiotic cocktail alleviates intestinal inflammation through improving gut microbiota and metabolites in colitis mice
topic gut microbiome
gut barrier
short-chain fatty acids (SCFAs)
liquid chromatograph mass spectrometer (LC-MS/MS)
inflammatory bowel disease (IBD)
fecal microbiota transplantation (FMT)
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.886061/full
work_keys_str_mv AT yefeizhu probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT yefeizhu probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT yefeizhu probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT yuxu probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT yuxu probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT xinyuewang probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT leipingrao probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT xuebingyan probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT renyuangao probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT tongyishen probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT yuanzhou probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT chengkong probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice
AT longxiangzhou probioticcocktailalleviatesintestinalinflammationthroughimprovinggutmicrobiotaandmetabolitesincolitismice